Nexus Dx Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Nexus Dx's estimated annual revenue is currently $9.3M per year.(i)
  • Nexus Dx's estimated revenue per employee is $251,000

Employee Data

  • Nexus Dx has 37 Employees.(i)
  • Nexus Dx grew their employee count by 6% last year.

Nexus Dx's People

NameTitleEmail/Phone
1
Head Finance And AdministrationReveal Email/Phone
2
Senior Director, Product DevelopmentReveal Email/Phone
3
President & CEOReveal Email/Phone
4
PD Scientist / Project LeadReveal Email/Phone
5
Quality Control Laboratory TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Nexus Dx?

Nexus Dx is a global provider of Near Patient Testing systems and advanced diagnostic solutions. The company is improving patient care by providing the medical community with rapid and reliable information at the point of care (POC), delivering patient information when and where it is needed most. Company Highlights: Primary focus on expansion of assay systems in the Near Patient Testing industry Multi-product revenue generating business Proprietary technologies and content Highly experienced management team Nexus Dx Inc.

keywords:N/A

N/A

Total Funding

37

Number of Employees

$9.3M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nexus Dx News

2022-04-20 - Cardiac POC Testing Devices and Kits Market Growth 2022 ...

Mitsubishi Chemical; LifeSign LLC. Nexus Dx; Inc. Roche Diagnostics International Ltd. Alfa Scientific Designs; Inc. Abbott; American Screening Corporation...

2022-04-13 - Digital Transformation & Green Transformation Webinar Series

WEBINAR 1. The nexus between DX and GX: How tech can accelerate green energy transition · WEBINAR 2. Overcoming obstacles to DX: How companies...

2022-04-06 - Biomarker-Guided Trial Led by University Hospital Hamburg ...

... measured via SphingoTec's rapid point of care platform Nexus IB10. ... by SphingoTec's subsidiary Nexus Dx Inc. (San Diego, CA, USA).

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.9M37-36%$141M
#2
$7.2M37-14%N/A
#3
$4.3M3723%N/A
#4
$7.4M379%N/A
#5
$3.5M37-12%N/A